Načítá se...
Down Syndrome and Dementia: A Randomized, Controlled Trial of Antioxidant Supplementation
Individuals with Down syndrome over age 40 years are at risk for developing dementia of the Alzheimer type and have evidence for chronic oxidative stress. There is a paucity of treatment trials for dementia in Down syndrome in comparison to Alzheimer disease in the general (non-Down syndrome) popula...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410645/ https://ncbi.nlm.nih.gov/pubmed/21739598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajmg.a.34114 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|